Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste.Most ...

The FDA requires labeling changes to the prescribing information for Pfizer and GSK RSV vaccines to include warnings about the risk for GBS.

The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 could turn out.

J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference.

Attruby's approval makes BridgeBio Pharma a competitor to Vyndaqel, with significant potential for growth and milestone ...

Vaxcyte's robust financial position supports its strategic flexibility and extended timelines. Read more to see why I rate ...

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

The FTSE 100 index fell 0.3% last night and is forecast to open today’s session flat at 8201. The pound is just below $1.22 ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

The latest round of the COVID inquiry focuses on vaccines and anti-viral treatment across the UK. Today we hear from several ...